Does BIVALIRUDIN Cause Off label use? 73 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 73 reports of Off label use have been filed in association with BIVALIRUDIN (BIVALIRUDIN). This represents 8.7% of all adverse event reports for BIVALIRUDIN.
73
Reports of Off label use with BIVALIRUDIN
8.7%
of all BIVALIRUDIN reports
9
Deaths
35
Hospitalizations
How Dangerous Is Off label use From BIVALIRUDIN?
Of the 73 reports, 9 (12.3%) resulted in death, 35 (47.9%) required hospitalization, and 12 (16.4%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BIVALIRUDIN. However, 73 reports have been filed with the FAERS database.
What Other Side Effects Does BIVALIRUDIN Cause?
Drug ineffective (148)
Haemorrhage (79)
Thrombosis in device (63)
Vascular stent thrombosis (63)
Heparin-induced thrombocytopenia (61)
Thrombosis (61)
Coagulation time abnormal (42)
Gastrointestinal haemorrhage (40)
Coronary artery thrombosis (33)
Cardiac arrest (28)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which BIVALIRUDIN Alternatives Have Lower Off label use Risk?
BIVALIRUDIN vs BLEOMYCIN
BIVALIRUDIN vs BLINATUMOMAB
BIVALIRUDIN vs BLONANSERIN
BIVALIRUDIN vs --BLOOD-COAGULATION FACTOR VIII FUSION PROTEIN WITH IMMUNOGLOBULIN G1 , ,-BIS WITH IMMUNOGLOBULIN G1
BIVALIRUDIN vs BOCEPREVIR